EUCTR2015-002212-32-DE进行中(未招募)1 期
Granulocyte colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: Amulticentre randomized Trial
niversität Leipzig0 个研究点目标入组 292 人开始时间: 2015年10月27日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 292
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Acute-on-chronic liver failure (ACLF) according to the consensus criteria recently defined by the CANONIC study group [Moreau 2013]. Patients with acute decompensation of cirrhosis [defined as acute development of one or more of the following: ascites (onset and/or worsening), hepatic encephalopathy (onset and/or worsening), gastrointestinal haemorrhage, bacterial infection] are classified as ACLF if one of the following applies:
- •single kidney failure (serum creatinine level = 2 mg/dl) or
- •single failure of one of the following organ systems: liver, coagulation, circulation, or respiration,
- •together with
- •a serum creatinine level ranging from 1.5 to < 2.0 mg/dl and/or mild to moderate hepatic encephalopathy or
- •single cerebral failure together with serum creatinine level ranging from 1.5 to < 2.0 mg/dl or
- •two or more organ failures.
- •Organ failures are defined according to the CLIF-C OFs [Jalan 2014].
- •2.Age = 18 years, male or female
- •3.Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 250
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 42
排除标准
- •1.Prior not curatively treated or active malignancies
- •2.Sickle cell disease
- •3.Septic shock, defined by the following symptom complex: bacteraemia AND SIRS AND shock
- •4.WBC-count of > 50 x 109/L
- •5.Known HIV infection
- •6.Known intolerance to filgrastim
- •7.Suspected lack of compliance
- •8.Pregnant or nursing women
- •9.Fertile women (within two years of their last menstruation) without appropriate contraceptive measures (implanon, injections, oral contraceptives, intrauterine devices, partner with vasectomy) while participating in the trial (participants using a hormone-based method have to be informed of possible effects from the trial medication on contraception).
- •10.Participation in other interventional trials
研究者
相似试验
已完成
不适用
Granulocyte colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: Amulticentre randomized trialacute-on-chronic liver failureK72.0Acute and subacute hepatic failureDRKS00011572niversität Leipzig176
已完成
不适用
G-CSF (granulocyte colony stimulating factor) in liver regeneratioAcute liver injuryDigestive System: Acute liver injuryDigestive SystemISRCTN55568608Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)20
已完成
1 期
Granulocyte-colony stimulating factor (G-CSF) mobilised autologous endothelial progenitor cells for refractory ischaemic heart diseasePatients with chronic ischaemic heart disease (IHD) on maximal medical therapy, who are not amenable to conventional revascularisation.Cardiovascular - Coronary heart diseaseACTRN12605000050651The Victor Chang Cardiac Research Institute20
已完成
不适用
Adult stem cells and G-CSF in chronic ischaemic heart diseaseChronic ischaemic heart diseaseCardiovascular - Coronary heart diseaseACTRN12607000354482St Vincent's Hospital20
已完成
2 期
Effect granulocyte colony stimulation factor (GCSF) versus placebo on implantation among infertile patients who underwent assisted reproductive technology (ART)Infertility.Female infertilityIRCT201501049014N52Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences30
